ArticleFrontiers in immunology2025
TRP-related gene signatures predict survival and the immune microenvironment in rectal cancer: a comprehensive bioinformatics study.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- High COMP expression promotes tumor cell proliferation and migration of rectal cancer, contributing to unfavorable prognosis and suppressive immune microenvironment.Discover oncology · 2026Article
- Myokine-mediated mechanisms of immune checkpoint inhibitors-associated colorectal injury and repair in rectal cancer.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The pathogenesis of rectal cancer (RC) involves a variety of biological mechanisms; however, the prognostic significance of temperature-sensitive receptor (TRP) channels in RC patients remains unclear. This study aimed to explore the role of TRP-related genes in RC prognosis and their potential clinical implications. Patients and methods: RNA-seq data for RC patients were obtained from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. TRP scores were calculated for TCGA samples, and modular genes were identified via weighted gene co-expression network analysis (WGCNA). Differentially expressed genes (DEGs) between RC and normal samples were identified via the "limma" software package. TRP-related genes (DETRPs) were identified by intersecting DEGs with modular genes. Biomarkers were identified through univariate and multivariate Cox analyses, as well as least absolute shrinkage and selective operator (LASSO) regression. Prognostic models and nomograms have been developed on the basis of these biomarkers. Additionally, enrichment analysis, immune cell infiltration assessment, and targeted drug prediction were performed. Biomarker expression was further validated experimentally. Results: A total of 246 DETRPs were identified by overlapping 1,989 DEGs and 265 modular genes, which were significantly associated with metabolic pathways. Five biomarkers (BMP5, DHRS11, GLTP, NFE2L3, and TMCC3) were selected to construct a prognostic model and a nomogram based on risk score and age. The risk model demonstrated significant correlations with clinical characteristics. Immune cell infiltration analysis revealed distinct immune cell ratios between high- and low-risk patients, with TMCC3 showing a positive correlation with central memory CD8 T cells and DHRS11 exhibiting a negative correlation with type 2 T helper cells. Furthermore, several targeted drugs, including MK-2206, pazopanib, JNK inhibitor VIII, PLX4720, and NU-7441, were associated with risk scores. Conclusion: This study identified five TRP-related biomarkers associated with RC prognosis, providing novel insights into the role of TRP channels in RC development. These findings may contribute to a deeper understanding of RC pathogenesis and offer potential targets for personalized therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.